We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
GenusPlus Group Limited is an engineering & construction business based in Australia. GenusPlus shares (GNP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. GenusPlus has a trailing 12-month revenue of around $221.8 million.
How to invest in the GenusPlus IPO
To invest in an IPO, you'll usually need to be registered with a participating broker or lead manager. This can be tricky for retail investors because there are usually only a few firms allocated for each IPO and they're typically full-service stockbrokers. In this case, the lead manager is Bell Potter.
If you're already registered with a broker, it always pays to check if they're offering IPO stock, as lead managers sometimes allocate a portion of shares on to other firms. Your other option is to buy shares in GenusPlus once it goes public. To do that, you'll need to be signed up to a share trading platform:
How to buy shares when GenusPlus lists
- Compare share trading platforms. To buy shares in an Australian-listed company, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for GenusPlus. Find the share by name or ticker symbol: GenusPlus. You can also search for any other shares traded publicly on exchanges available within your chosen platform.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until GenusPlus reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At price of at you're buying the shares, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of GenusPlus. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
GenusPlus share priceUse our graph to track the performance of GNP stocks over time.
GenusPlus shares at a glance
|52-week range||$0.95 - $1.12|
|50-day moving average||$1.0139|
|200-day moving average||$1.0198|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.059|
Compare share trading platforms
Is it a good time to buy GenusPlus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is GenusPlus under- or over-valued?
Valuing GenusPlus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GenusPlus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GenusPlus's P/E ratio
GenusPlus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, GenusPlus shares trade at around 16x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
GenusPlus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.7 million (£0.0 million).
The EBITDA is a measure of a GenusPlus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$221.8 million|
|Operating margin TTM||4.31%|
|Gross profit TTM||$125.2 million|
|Return on assets TTM||7.37%|
|Return on equity TTM||31.46%|
|Market capitalisation||$148.6 million|
TTM: trailing 12 months
GenusPlus share dividends
We're not expecting GenusPlus to pay a dividend over the next 12 months.
GenusPlus Group Limited provides infrastructure services in Australia. The company's services cover power and telecommunications transmission and distribution; underground network installation services, which range from optic fiber for telecommunications to underground power and civil works; switchyards, substation, communications, and renewable energy; design, construction, commissioning, fault works, and maintenance; high voltage (HV) testing, commissioning, and engineering services, including HV cable jointing, HV testing, protection relay testing, fault location, and high voltage maintenance; electrical and instrumentation services; and construction and maintenance. It also provides integrated engineering and training, and related support services. The company provides its services for customers in the infrastructure, utilities, mining and resources, government and private, telecommunications, power distribution and generation, commercial, industrial, civil, and oil and gas sectors. GenusPlus Group Limited was incorporated in 2017 and is headquartered in Belmont, Australia.
Frequently asked questions
Ask an Expert